OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder

NCT01945489 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

BIOLOGICAL: onabotulinumtoxinA
DRUG: Normal saline

Sponsor

Allergan